株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

放出制御ドラッグデリバリーの世界市場の分析・予測

Global Controlled Release Drug Delivery Market 2019-2025

発行 Orion Market Research Pvt Ltd 商品コード 869650
出版日 ページ情報 英文
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.53円で換算しております。
Back to Top
放出制御ドラッグデリバリーの世界市場の分析・予測 Global Controlled Release Drug Delivery Market 2019-2025
出版日: 2019年06月15日 ページ情報: 英文
概要

当レポートでは、世界の放出制御ドラッグデリバリーの市場を調査し、市場の定義と概要、市場成長への各種影響因子の分析、タイプ・技術・地域/主要国別の動向と市場規模の推移と予測、競合環境、主要企業のプロファイルなどをまとめています。

第1章 レポートサマリー

第2章 市場概要・考察

  • 調査範囲
  • アナリストの考察・現在の市場動向
  • 規則・規制

第3章 競合情勢

  • 競合ダッシュボード
  • 主要戦略分析
  • 主要企業分析
    • Pfizer, Inc.
    • AstraZeneca PLC
    • Bristol-Myers Squibb, Co.
    • Merck and Co., Inc.
    • Mylan N.V.

第4章 市場影響因子

  • 促進要因
  • 抑制要因
  • 市場機会

第5章 市場分析・予測:各種区分別

  • タイプ別
    • 定量噴霧式吸入器 (MDI)
    • 注射器
    • 経皮・眼科用パッチ
    • 輸液ポンプ
    • 経口DDS
  • 技術別
    • Wurster法 (薬剤コーティング)
    • コアセルベーション
    • マイクロカプセル化
    • インプラント
    • 経皮的技術
    • 標的デリバリー
    • その他 (リポソーム)

第6章 市場分析・予測:地域・主要国別

  • 北米
  • 欧州
  • アジア太平洋
  • その他

第7章 企業プロファイル

  • Abbott Laboratories, Inc.
  • Alkermes, Inc.
  • Allergan PLC
  • Aradigm Corp.
  • AstraZeneca PLC
  • BDD, Ltd.
  • Bristol-Myers Squibb Co.
  • Catalent, Inc.
  • Coating Place, Inc.
  • Collegium Pharmaceutical, Inc.
  • Colorcon, Inc.
  • DowDuPont, Inc.
  • Endo Pharmaceuticals, PLC
  • Intellipharmaceutics International Inc.
  • Janssen Pharmaceuticals, Inc. (Johnson and Johnson Services, Inc.)
  • Mallinckrodt PLC
  • Mayne Pharma Group, Ltd.
  • Merck and Co., Inc.
  • Mylan N.V.
  • Novartis AG
  • Orbis Biosciences, Inc.
  • Pfizer, Inc.
  • ProMed Pharma
  • Purdue Pharma L.P.
  • Sun Pharmaceuticals Industries, Ltd.
  • Teva Pharmaceutical Industries, Ltd.
  • Tris Pharma, Inc.
図表

List of Tables

  • 1. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY TYPE, 2018-2025 ($ MILLION)
  • 2. GLOBAL METERED DOSE INHALERS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 3. GLOBAL INJECTABLE MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 4. GLOBAL TRANSDERMAL & OCULAR PATACHES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 5. GLOBAL INFUSIONS PUMPS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 6. GLOBAL ORAL CONTROLLED DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 7. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2018-2025 ($ MILLION)
  • 8. GLOBAL WUSTER TECHNIQUE MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 9. GLOBAL MICRO ENCAPSULATION MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 10. GLOBAL COACERVATION MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 11. GLOBAL TRANSDERMAL MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 12. GLOBAL TARGET DELIVERY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 13. GLOBAL IMPLANTS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 14. GLOBAL OTHER MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 15. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2018-2025 ($ MILLION)
  • 16. NORTH AMERICAN CONTROLLED RELEASE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 17. NORTH AMERICAN CONTROLLED RELEASE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY TYPE, 2018-2025 ($ MILLION)
  • 18. NORTH AMERICAN CONTROLLED RELEASE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2018-2025 ($ MILLION)
  • 19. NORTH AMERICAN CONTROLLED RELEASE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY RELEASE MECHANISM, 2018-2025 ($ MILLION)
  • 20. EUROPEAN CONTROLLED RELEASE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 21. EUROPEAN CONTROLLED RELEASE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY TYPE, 2018-2025 ($ MILLION)
  • 22. EUROPEAN CONTROLLED RELEASE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2018-2025 ($ MILLION)
  • 23. EUROPEAN CONTROLLED RELEASE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY RELEASE MECHANISM, 2018-2025 ($ MILLION)
  • 24. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 25. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY TYPE, 2018-2025 ($ MILLION)
  • 26. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2018-2025 ($ MILLION)
  • 27. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY RELEASE MECHANISM, 2018-2025 ($ MILLION)
  • 28. REST OF THE WORLD CONTROLLED RELEASE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY TYPE, 2018-2025 ($ MILLION)
  • 29. REST OF THE WORLD CONTROLLED RELEASE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2018-2025 ($ MILLION)
  • 30. REST OF THE WORLD CONTROLLED RELEASE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY RELEASE MECHANISM, 2018-2025 ($ MILLION)

List of Figures

  • 1. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SHARE BY TYPE, 2018 VS 2025 (%)
  • 2. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SHARE BY TECHNOLOGY, 2018 VS 2025 (%)
  • 3. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SHARE BY RELEASE MECHANISM, 2018 VS 2025 (%)
  • 4. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SHARE BY GEOGRAPHY, 2018 VS 2025 (%)
  • 5. US SPORTS CONTROLLED RELEASED DRUG DELIVERY MARKET SIZE, 2018-2025 ($ MILLION)
  • 6. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, 2018-2025 ($ MILLION)
  • 7. UK CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, 2018-2025 ($ MILLION)
  • 8. FRANCE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, 2018-2025 ($ MILLION)
  • 9. GERMANY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, 2018-2025 ($ MILLION)
  • 10. ITALY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, 2018-2025 ($ MILLION)
  • 11. SPAIN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, 2018-2025 ($ MILLION)
  • 12. ROE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, 2018-2025 ($ MILLION)
  • 13. INDIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, 2018-2025 ($ MILLION)
  • 14. CHINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, 2018-2025 ($ MILLION)
  • 15. JAPAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, 2018-2025 ($ MILLION)
  • 16. REST OF ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, 2018-2025 ($ MILLION)
  • 17. REST OF THE WORLD CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, 2018-2025 ($ MILLION)
目次
Product Code: OMR2019706

Global Controlled Release Drug Delivery Market Size, Share & Trends Analysis Report by Type (Metered Dose Inhalers, Injectable, Transdermal and Ocular Patches, Infusion Pumps, and Oral Controlled-drug Delivery Systems), by Technology (Wurster Technique, Coacervation, Micro Encapsulation, Implants, Transdermal, Targeted Delivery, and Others), and Forecast, 2019-2025

Controlled release drug delivery systems deliver the drug for a specified period of time at a predetermined rate during the treatment. Controlled release drug delivery uses drug encapsulating devices from which therapeutic agents can be released for long periods of time, ranging from days to months, at controlled rates. Such systems offer numerous benefits over traditional drug delivery methods, including customizing drug release rates, protecting fragile drugs, and enhancing patient comfort and compliance. Moreover, controlled release drug delivery systems allow dosage frequency reduction, lower plasma drug levels fluctuation, uniform drug effect, and enhanced therapeutic efficacy ratio.

The market of controlled release drug delivery system is segmented into technology and type. Targeted delivery offers a preferred site of action and removes drugs from sites that could lead to drug toxicity. Targeted technologies provide drug localization, resulting in uniform effects, reduced fluctuations in circulating drug levels, and low side effects risk. Whereas, microencapsulation has gained traction as many companies have adopted this method to alter the delivery mechanism. Compared to conventional delivery systems, microencapsulation offers lower toxicity. Moreover, implantable systems have reduced side effects, increased efficiency, convenience and delivery over a specified period of time for linear drugs.

Geographically, the market has been segmented on the basis of four major regions which includes North America, Europe, Asia-Pacific and Rest of the World. The market has the significant share in North America owing to increased government initiatives to develop controlled release drug delivery and the presence of prominent market players in this region. Asia-Pacific market is expected to experience the fastest growth during the forecast period. This can be attributed to the increased pharmaceutical spending, and increased investment and R&D activities in countries of this region by pharmaceutical and biopharmaceutical companies. The key players of this market are Merck and Co., Inc., Orbis Biosciences, Inc., Pfizer, Inc., AstraZeneca PLC, Bristol-Myers Squibb Co., Mylan N.V. and Janssen Pharmaceuticals, Inc.

Research Methodology

The market study of the global controlled release drug delivery market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity in our reports.

Secondary Sources Include

  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report is intended for government and private companies for overall market analysis and competitive analysis. The report provides in-depth analysis on market size, intended quality of the service preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

  • 1. Global Controlled Release Drug Delivery Market Research and Analysis by Type
  • 2. Global Controlled Release Drug Delivery Market Research and Analysis by Technology
  • The Report Covers

    • Comprehensive research methodology of the global controlled release drug delivery market.
    • This report also includes a detailed and extensive market overview with key analyst insights.
    • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
    • Analysis of regional regulations and other government policies impacting the global controlled release drug delivery market.
    • Insights about market determinants which are stimulating the global controlled release drug delivery market.
    • Detailed and extensive market segments with regional distribution of forecasted revenues.
    • Extensive profiles and recent developments of market players.

    Table of Contents

    1. Report Summary

    • 1.1. Research Methods and Tools
    • 1.2. Market Breakdown
      • 1.2.1. By Segments
      • 1.2.2. By Geography

    2. Market Overview and Insights

    • 2.1. Scope of the Report
    • 2.2. Analyst Insight & Current Market Trends
      • 2.2.1. Key Findings
      • 2.2.2. Recommendations
      • 2.2.3. Conclusion
    • 2.3. Rules & Regulations

    3. Competitive Landscape

    • 3.1. Competitive Dashboard
    • 3.2. Key Strategy Analysis
    • 3.3. Key Company Analysis
      • 3.3.1. Pfizer, Inc.
        • 3.3.1.1. Overview
        • 3.3.1.2. Financial Analysis
        • 3.3.1.3. SWOT Analysis
        • 3.3.1.4. Recent Developments
      • 3.3.2. AstraZeneca PLC
        • 3.3.2.1. Overview
        • 3.3.2.2. Financial Analysis
        • 3.3.2.3. SWOT Analysis
        • 3.3.2.4. Recent Developments
      • 3.3.3. Bristol-Myers Squibb, Co.
        • 3.3.3.1. Overview
        • 3.3.3.2. Financial Analysis
        • 3.3.3.3. SWOT Analysis
        • 3.3.3.4. Recent Developments
      • 3.3.4. Merck and Co., Inc.
        • 3.3.4.1. Overview
        • 3.3.4.2. Financial Analysis
        • 3.3.4.3. SWOT Analysis
        • 3.3.4.4. Recent Developments
      • 3.3.5. Mylan N.V.
        • 3.3.5.1. Overview
        • 3.3.5.2. Financial Analysis
        • 3.3.5.3. SWOT Analysis
        • 3.3.5.4. Recent Developments

    4. Market Determinants

    • 4.1. Motivators
    • 4.2. Restraints
    • 4.3. Opportunities

    5. Market Segmentation

    • 5.1. Global Controlled Release Drug Delivery Market by Type
      • 5.1.1. Metered Dose Inhalers
      • 5.1.2. Injectable
      • 5.1.3. Transdermal and Ocular Patches
      • 5.1.4. Infusion Pumps
      • 5.1.5. Oral Controlled-Drug Delivery Systems
    • 5.2. Global Controlled Release Drug Delivery Market by Technology
      • 5.2.1. Wurster technique (Drug Coating)
      • 5.2.2. Coacervation
      • 5.2.3. Micro Encapsulation
      • 5.2.4. Implants
      • 5.2.5. Transdermal
      • 5.2.6. Targeted Delivery
      • 5.2.7. Others (Liposomes)

    6. Regional Analysis

    • 6.1. North America
      • 6.1.1. United States
      • 6.1.2. Canada
    • 6.2. Europe
      • 6.2.1. UK
      • 6.2.2. Germany
      • 6.2.3. Italy
      • 6.2.4. Spain
      • 6.2.5. France
      • 6.2.6. Rest of Europe
    • 6.3. Asia-Pacific
      • 6.3.1. China
      • 6.3.2. India
      • 6.3.3. Japan
      • 6.3.4. Rest of Asia-Pacific
    • 6.4. Rest of the World

    7. Company Profiles

    • 7.1. Abbott Laboratories, Inc.
    • 7.2. Alkermes, Inc.
    • 7.3. Allergan PLC
    • 7.4. Aradigm Corp.
    • 7.5. AstraZeneca PLC
    • 7.6. BDD, Ltd.
    • 7.7. Bristol-Myers Squibb Co.
    • 7.8. Catalent, Inc.
    • 7.9. Coating Place, Inc.
    • 7.10. Collegium Pharmaceutical, Inc.
    • 7.11. Colorcon, Inc.
    • 7.12. DowDuPont, Inc.
    • 7.13. Endo Pharmaceuticals, PLC
    • 7.14. Intellipharmaceutics International Inc.
    • 7.15. Janssen Pharmaceuticals, Inc. (Johnson and Johnson Services, Inc.)
    • 7.16. Mallinckrodt PLC
    • 7.17. Mayne Pharma Group, Ltd.
    • 7.18. Merck and Co., Inc.
    • 7.19. Mylan N.V.
    • 7.20. Novartis AG
    • 7.21. Orbis Biosciences, Inc.
    • 7.22. Pfizer, Inc.
    • 7.23. ProMed Pharma
    • 7.24. Purdue Pharma L.P.
    • 7.25. Sun Pharmaceuticals Industries, Ltd.
    • 7.26. Teva Pharmaceutical Industries, Ltd.
    • 7.27. Tris Pharma, Inc.
    Back to Top